Back to top
more

Actinium Pharmaceuticals (ATNM)

(Delayed Data from AMEX)

$8.73 USD

8.73
196,224

-0.17 (-1.91%)

Updated May 10, 2024 04:00 PM ET

After-Market: $8.72 -0.01 (-0.11%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.20%
2Buy18.04%
3Hold9.52%
4Sell5.20%
5Strong Sell2.60%
S&P50011.13%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

F Value F Growth B Momentum F VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 37% (94 out of 251)

Industry: Medical - Drugs

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Brokerage Reports

Research for ATNM

The Zacks Equity Research reports, or ZER for short, are our in-house, independently produced research reports.

The ever popular one-page Snapshot reports are generated for virtually every single Zacks Ranked stock. It's packed with all of the company's key stats and salient decision making information. Including the Zacks Rank, Zacks Industry Rank, Style Scores, the Price, Consensus & Surprise chart, graphical estimate analysis and how a stocks stacks up to its peers.

The detailed multi-page Analyst report does an even deeper dive on the company's vital statistics. In addition to all of the proprietary analysis in the Snapshot, the report also visually displays the four components of the Zacks Rank (Agreement, Magnitude, Upside and Surprise); provides a comprehensive overview of the company business drivers, complete with earnings and sales charts; a recap of their last earnings report; and a bulleted list of reasons to buy or sell the stock. It also includes an industry comparison table to see how your stock compares to its expanded industry, and the S&P 500.

Researching stocks has never been so easy or insightful as with the ZER Analyst and Snapshot reports.

Learn more about Zacks Equity Research reports

See more Zacks Equity Research reports

 

0 items in cart

Actinium Pharmaceuticals, Inc. [ATNM]

Reports for Purchase

Showing records 21 - 40 ( 91 total )

Company: Actinium Pharmaceuticals, Inc.

Industry: Medical - Drugs

Record: 21

12/12/2022

Company Report

Pages: 7

Actimab-A / CLAG-M Combination Data Don''t Disappoint at ASH; Full Positive SIERRA Data Likely Early 2023

Provider: H.C. Wainwright & Co., Inc.

Analyst: PANTGINIS J

Price: 12.50

Research Provided by a Third Party

Company: Actinium Pharmaceuticals, Inc.

Industry: Medical - Drugs

Record: 22

11/15/2022

Company Report

Pages: 7

3Q22 Results; Full Data Looks From SIERRA and Actimab-A/CLAG Coming Soon

Provider: H.C. Wainwright & Co., Inc.

Analyst: PANTGINIS J

Price: 12.50

Research Provided by a Third Party

Company: Actinium Pharmaceuticals, Inc.

Industry: Medical - Drugs

Record: 23

11/03/2022

Company Report

Pages: 7

Actimab-A / CLAG-M r/rAML Study Shows Important Survival Benefit in Tough Population; Reiterate Buy

Provider: H.C. Wainwright & Co., Inc.

Analyst: PANTGINIS J

Price: 12.50

Research Provided by a Third Party

Company: Actinium Pharmaceuticals, Inc.

Industry: Medical - Drugs

Record: 24

10/31/2022

Company Report

Pages: 6

Happy Monday with p<0.0001; SIERRA Hits Big; Price Target Increased to $53

Provider: H.C. Wainwright & Co., Inc.

Analyst: PANTGINIS J

Price: 12.50

Research Provided by a Third Party

Company: Actinium Pharmaceuticals, Inc.

Industry: Medical - Drugs

Record: 25

09/21/2022

Company Report

Pages: 7

Huge 4Q Ahead While Cash Strong; SIERRA Data Very Close

Provider: H.C. Wainwright & Co., Inc.

Analyst: PANTGINIS J

Price: 12.50

Research Provided by a Third Party

Company: Actinium Pharmaceuticals, Inc.

Industry: Medical - Drugs

Record: 26

09/06/2022

Industry Report

Pages: 11

Time to Step Up for These Catalysts; Making Real Differences

Provider: H.C. Wainwright & Co., Inc.

Analyst: PANTGINIS J

Price: 12.50

Research Provided by a Third Party

Company: Actinium Pharmaceuticals, Inc.

Industry: Medical - Drugs

Record: 27

08/15/2022

Company Report

Pages: 7

2Q22 Results; Clinical and Regulatory Milestones Remain On Track; SIERRA Top-Line Data By Year End

Provider: H.C. Wainwright & Co., Inc.

Analyst: PANTGINIS J

Price: 12.50

Research Provided by a Third Party

Company: Actinium Pharmaceuticals, Inc.

Industry: Medical - Drugs

Record: 28

08/15/2022

Company Report

Pages: 7

2Q22 Results; Clinical and Regulatory Milestones Remain On Track

Provider: H.C. Wainwright & Co., Inc.

Analyst: PANTGINIS J

Price: 12.50

Research Provided by a Third Party

Company: Actinium Pharmaceuticals, Inc.

Industry: Medical - Drugs

Record: 29

05/16/2022

Company Report

Pages: 7

1Q22 Results; Cash to Mid-2025; Our SIERRA Confidence Remains High For Positive Readout Later This Year

Provider: H.C. Wainwright & Co., Inc.

Analyst: PANTGINIS J

Price: 12.50

Research Provided by a Third Party

Company: Actinium Pharmaceuticals, Inc.

Industry: Medical - Drugs

Record: 30

04/25/2022

Company Report

Pages: 6

Another Confidence Boost From SIERRA As We Project Positive Outcome in 3Q22

Provider: H.C. Wainwright & Co., Inc.

Analyst: PANTGINIS J

Price: 12.50

Research Provided by a Third Party

Company: Actinium Pharmaceuticals, Inc.

Industry: Medical - Drugs

Record: 31

04/12/2022

Company Report

Pages: 9

AACR Data Support Early Anti-Tumor Activity of HER3-Targeted Radiotherapy; Positive Efficacy Solo and in Combo

Provider: H.C. Wainwright & Co., Inc.

Analyst: PANTGINIS J

Price: 12.50

Research Provided by a Third Party

Company: Actinium Pharmaceuticals, Inc.

Industry: Medical - Drugs

Record: 32

04/12/2022

Company Report

Pages: 10

Radiopharma Gets Another Boost; Iomab-B Partnered in EUMENA; SIERRA Top-Line Data in 3Q22

Provider: H.C. Wainwright & Co., Inc.

Analyst: PANTGINIS J

Price: 12.50

Research Provided by a Third Party

Company: Actinium Pharmaceuticals, Inc.

Industry: Medical - Drugs

Record: 33

03/28/2022

Company Report

Pages: 7

2021 Results; SIERRA Prepped for 3Q22 Data and Projected Major Inflection; Reiterate Buy

Provider: H.C. Wainwright & Co., Inc.

Analyst: PANTGINIS J

Price: 12.50

Research Provided by a Third Party

Company: Actinium Pharmaceuticals, Inc.

Industry: Medical - Drugs

Record: 34

03/02/2022

Industry Report

Pages: 18

Reasons to Sit Down with These Healthcare/Biotech Management

Provider: Roth Capital Partners, Inc.

Analyst: PIROS E

Price: 25.00

Research Provided by a Third Party

Company: Actinium Pharmaceuticals, Inc.

Industry: Medical - Drugs

Record: 35

02/22/2022

Daily Note

Pages: 5

AWE Collaboration Further Expands Portfolio of Potential First-in-Class Radiotherapies

Provider: H.C. Wainwright & Co., Inc.

Analyst: PANTGINIS J

Price: 5.00

Research Provided by a Third Party

Company: Actinium Pharmaceuticals, Inc.

Industry: Medical - Drugs

Record: 36

02/02/2022

Industry Report

Pages: 90

Nervous Markets, But We See Outperforming Names: H.C. Wainwright''s 2022 Top Picks

Provider: H.C. Wainwright & Co., Inc.

Analyst: Research Department

Price: 75.00

Research Provided by a Third Party

Company: Actinium Pharmaceuticals, Inc.

Industry: Medical - Drugs

Record: 37

01/05/2022

Daily Note

Pages: 7

New Collaboration to Evaluate the Efficacy of Actimab-A in AML

Provider: H.C. Wainwright & Co., Inc.

Analyst: PANTGINIS J

Price: 12.50

Research Provided by a Third Party

Company: Actinium Pharmaceuticals, Inc.

Industry: Medical - Drugs

Record: 38

12/14/2021

Company Report

Pages: 9

Actimab-A Continues to Impress at ASH as Combo Studies Expand

Provider: H.C. Wainwright & Co., Inc.

Analyst: PANTGINIS J

Price: 12.50

Research Provided by a Third Party

Company: Actinium Pharmaceuticals, Inc.

Industry: Medical - Drugs

Record: 39

12/13/2021

Company Report

Pages: 6

SIERRA Profile Shows Strong Ongoing Durability with Iomab-B; Top-Line Data Mid-22

Provider: H.C. Wainwright & Co., Inc.

Analyst: PANTGINIS J

Price: 12.50

Research Provided by a Third Party

Company: Actinium Pharmaceuticals, Inc.

Industry: Medical - Drugs

Record: 40

11/16/2021

Company Report

Pages: 8

SITC Highlights Efficacy of ARC Therapy in Solid and Liquid Tumors; 3Q21 Results

Provider: H.C. Wainwright & Co., Inc.

Analyst: PANTGINIS J

Price: 12.50

Research Provided by a Third Party